Coherus BioSciences: Q2 Earnings Snapshot
By AP News
Published - Aug 08, 2024, 05:03 PM ET
Last Updated - Aug 08, 2024, 05:03 PM EDT
REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Thursday reported a loss of $12.9 million in its second quarter.
On a per-share basis, the Redwood City, California-based company said it had a loss of 11 cents. Losses, adjusted for one-time gains and costs, were 14 cents per share.
The drug developer posted revenue of $65 million in the period, which beat Street forecasts. Four analysts surveyed by Zacks expected $57.1 million.
_____
